TrialBMC gastroenterology2023

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study.

Hyun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.